Cargando…

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms

Chromogranin A (CgA) is a well-established marker for diagnosis and follow up of patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). Recently, it has been shown that plasma levels of CgA correlate with tumor load and predict survival of patients with NEN of the small bowel. It i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koenig, Alexander, Krug, Sebastian, Mueller, Daniela, Barth, Peter J., Koenig, Ute, Scharf, Michael, Ellenrieder, Volker, Michl, Patrick, Moll, Roland, Homayunfar, Kia, Kann, Peter Herbert, Stroebel, Philipp, Gress, Thomas M., Rinke, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726657/ https://www.ncbi.nlm.nih.gov/pubmed/29232390 http://dx.doi.org/10.1371/journal.pone.0188876

Ejemplares similares

Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome
por: Krug, Sebastian, et al.
Publicado: (2019)

Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm
por: Boch, Michael, et al.
Publicado: (2014)

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms – Predictive and Prognostic Markers for Treatment Stratification
por: Krug, Sebastian, et al.
Publicado: (2015)

Multicenter Analysis of Presacral Neuroendocrine Neoplasms—Clinicopathological Characterization and Treatment Outcomes of a Rare Disease
por: Matrood, Sami, et al.
Publicado: (2021)

Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors
por: Rinke, Anja, et al.
Publicado: (2012)

Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature
por: Krug, Sebastian, et al.
Publicado: (2016)

CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors
por: Krug, Sebastian, et al.
Publicado: (2020)

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors
por: Mueller, Daniela, et al.
Publicado: (2016)

Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2019)

Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms
por: Apostolidis, Leonidas, et al.
Publicado: (2021)

Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2020)

Clinicopathological Spectrum of Primary and Metastatic Neuroendocrine Neoplasms
por: Hashmi, Atif A, et al.
Publicado: (2020)

Clinicopathologic and Molecular Features of Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gallbladder
por: Alawad, Mouyed, et al.
Publicado: (2020)

The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease
por: Krug, Sebastian, et al.
Publicado: (2022)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017)

Simultaneous Onset of Ulcerative Colitis and Disseminated Pyoderma Gangrenosum
por: Neesse, Albrecht, et al.
Publicado: (2007)

Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
por: Schade, Sebastian, et al.
Publicado: (2022)

Neuroendocrine Neoplasms in Rare Locations: Clinicopathological Features and Review of the Literature
por: del Arco, Cristina Díaz, et al.
Publicado: (2018)

Clinicopathological characteristics of rectal multiple neuroendocrine neoplasms and literature review
por: Zheng, Xiuli, et al.
Publicado: (2023)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Krug, Sebastian, et al.
Publicado: (2021)

Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality
por: Krug, Sebastian, et al.
Publicado: (2021)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
por: Shi, Huiying, et al.
Publicado: (2020)

Clinicopathological features, endoscopic features, and treatment analysis of gastric neuroendocrine neoplasms
por: Huang, Ju, et al.
Publicado: (2022)

Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients
por: Huang, Yu-Chen, et al.
Publicado: (2021)

Unusual Microsatellite-Instable Mixed Neuroendocrine and Non-neuroendocrine Neoplasm: A Clinicopathological Inspection and Literature Review
por: Pereira, Daniela, et al.
Publicado: (2023)

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021)

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study
por: Zhang, Panpan, et al.
Publicado: (2018)

Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China
por: Fang, Cheng, et al.
Publicado: (2017)

Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience
por: Babu Kanakasetty, Govind, et al.
Publicado: (2016)

Neuroendocrine Neoplasms of the Gallbladder: A Clinicopathological Analysis of 13 Patients and a Review of the Literature
por: Wang, Pengyan, et al.
Publicado: (2021)

Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe
por: Jann, Henning, et al.
Publicado: (2023)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Vessel-Sparing Lymphadenectomy Should Be Performed in Small Intestine Neuroendocrine Neoplasms
por: Bartsch, Detlef K., et al.
Publicado: (2022)

IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2
por: Sperling, Florian, et al.
Publicado: (2022)

An 11-year retrospective study: clinicopathological and survival analysis of gastro-entero-pancreatic neuroendocrine neoplasm
por: Liu, Hua, et al.
Publicado: (2020)

Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1
por: Sonoda, Akari, et al.
Publicado: (2020)

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
por: Neesse, Albrecht, et al.
Publicado: (2013)

Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2019)

Sporadic pancreatic neuroendocrine neoplasms: A retrospective clinicopathological and outcome analysis from a Latvian study group
por: Ptasnuka, Margarita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pkla5qp92p1go7tac1juptipom